{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,24]],"date-time":"2025-08-24T01:51:20Z","timestamp":1756000280035,"version":"3.30.2"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,12,18]]},"DOI":"10.7759\/cureus.75928","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T09:45:46Z","timestamp":1734515146000},"source":"Crossref","is-referenced-by-count":1,"title":["Treatment Patterns, Characteristics, and Probable Acute Medication Overprescription Among Patients With Migraine in Japan: A Retrospective Cross-Sectional and Longitudinal Analysis of Health Insurance Claims Data"],"prefix":"10.7759","author":[{"given":"Masahito","family":"Katsuki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Matsumori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taisuke","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuya","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichi","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenta","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihito","family":"Koh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomichi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Hanaoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fuminori","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"","author":"Headache Clinical Practice Guideline Development Committee","year":"2021","unstructured":"Headache Clinical Practice Guideline Development Committee. Clinical Practice Guideline for Headache Disorders (Book in Japanese). Japanese Society of Neurology, Japanese Headache Society, Japanese Society of Neurological Therapeutics (ed): Igaku-Shoin, Tokyo, Japan; 2021. https:\/\/www.jsnt.gr.jp\/guideline\/img\/zutsu_2021.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.25419","article-title":"The efficacy of Japanese herbal kampo medicine as an acute and prophylactic medication to treat chronic daily headache and medication overuse headache: single arm retrospective study","volume":"14","author":"Katsuki M","year":"2022","unstructured":"Katsuki M, Kashiwagi K, Kawamura S, Koh A. The efficacy of Japanese herbal kampo medicine as an acute and prophylactic medication to treat chronic daily headache and medication overuse headache: single arm retrospective study. Cureus. 2022, 14:e25419. 10.7759\/cureus.25419","journal-title":"Cureus"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11164707","article-title":"Questionnaire-based survey during COVID-19 vaccination on the prevalence of elderly\u2019s migraine, chronic daily headache, and medication-overuse headache in one Japanese city\u2014Itoigawa Hisui Study","volume":"11","author":"Katsuki M","year":"2022","unstructured":"Katsuki M, Kawahara J, Matsumori Y, et al.. Questionnaire-based survey during COVID-19 vaccination on the prevalence of elderly\u2019s migraine, chronic daily headache, and medication-overuse headache in one Japanese city\u2014Itoigawa Hisui Study. J Clin Med. 2022, 11:4-6. 10.3390\/jcm11164707","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000063322.14078.90","article-title":"Rates and predictors for relapse in medication overuse headache: a 1-year prospective study","volume":"60","author":"Katsarava Z","year":"2003","unstructured":"Katsarava Z, Limmroth V, Finke M, Diener HC, Fritsche G. Rates and predictors for relapse in medication overuse headache: a 1-year prospective study. Neurology. 2003, 60:1682-3. 10.1212\/01.wnl.0000063322.14078.90","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/head.14472","article-title":"Headache education by leaflet distribution during COVID-19 vaccination and school-based on-demand e-learning: Itoigawa Geopark Headache Awareness Campaign","volume":"63","author":"Katsuki M","year":"2023","unstructured":"Katsuki M, Matsumori Y, Kawahara J, et al.. Headache education by leaflet distribution during COVID-19 vaccination and school-based on-demand e-learning: Itoigawa Geopark Headache Awareness Campaign. Headache. 2023, 63:429-40. 10.1111\/head.14472","journal-title":"Headache"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.2165\/0023210-200822120-00003","article-title":"Medication overuse headache: awareness, detection and treatment","volume":"22","author":"Rapoport AM","year":"2008","unstructured":"Rapoport AM. Medication overuse headache: awareness, detection and treatment. CNS Drugs. 2008, 22:995-1004. 10.2165\/0023210-200822120-00003","journal-title":"CNS Drugs"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/03331024211024153","article-title":"Delivery of care for migraine in the Asian Oceanian region: a cross-sectional study","volume":"41","author":"Roxas A Jr","year":"2021","unstructured":"Roxas A Jr, Quiles LE, Wang SJ. Delivery of care for migraine in the Asian Oceanian region: a cross-sectional study. Cephalalgia. 2021, 41:1348-58. 10.1177\/03331024211024153","journal-title":"Cephalalgia"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s11916-017-0651-7","article-title":"Headache in resource-Limited settings","volume":"21","author":"Woldeamanuel YW","year":"2017","unstructured":"Woldeamanuel YW. Headache in resource-Limited settings. Curr Pain Headache Rep. 2017, 21:51. 10.1007\/s11916-017-0651-7","journal-title":"Curr Pain Headache Rep"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0839-1","article-title":"Poor medical care for people with migraine in Europe - evidence from the Eurolight study","volume":"19","author":"Katsarava Z","year":"2018","unstructured":"Katsarava Z, Mania M, Lampl C, Herberhold J, Steiner TJ. Poor medical care for people with migraine in Europe - evidence from the Eurolight study. J Headache Pain. 2018, 19:10. 10.1186\/s10194-018-0839-1","journal-title":"J Headache Pain"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1111\/head.14259","article-title":"Diagnosis, consultation, treatment, and impact of migraine in the US: results of the OVERCOME (US) study","volume":"62","author":"Lipton RB","year":"2022","unstructured":"Lipton RB, Nicholson RA, Reed ML, et al.. Diagnosis, consultation, treatment, and impact of migraine in the US: results of the OVERCOME (US) study. Headache. 2022, 62:122-40. 10.1111\/head.14259","journal-title":"Headache"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2023-075612","article-title":"Impact of areal socioeconomic status on prehospital delay of acute ischaemic stroke: retrospective cohort study from a prefecture-wide survey in Japan","volume":"13","author":"Fukuda H","year":"2023","unstructured":"Fukuda H, Hyohdoh Y, Ninomiya H, et al.. Impact of areal socioeconomic status on prehospital delay of acute ischaemic stroke: retrospective cohort study from a prefecture-wide survey in Japan. BMJ Open. 2023, 13:e075612. 10.1136\/bmjopen-2023-075612","journal-title":"BMJ Open"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13089-w","article-title":"Analysis of the association between areal socioeconomic deprivation levels and viral hepatitis B and C infections in Japanese municipalities","volume":"22","author":"Okui T","year":"2022","unstructured":"Okui T, Nakashima N. Analysis of the association between areal socioeconomic deprivation levels and viral hepatitis B and C infections in Japanese municipalities. BMC Public Health. 2022, 22:681. 10.1186\/s12889-022-13089-w","journal-title":"BMC Public Health"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2021.100204","article-title":"Geographical socioeconomic inequalities in healthy life expectancy in Japan, 2010-2014: an ecological study","volume":"14","author":"Kataoka A","year":"2021","unstructured":"Kataoka A, Fukui K, Sato T, et al.. Geographical socioeconomic inequalities in healthy life expectancy in Japan, 2010-2014: an ecological study. Lancet Reg Health West Pac. 2021, 14:100204. 10.1016\/j.lanwpc.2021.100204","journal-title":"Lancet Reg Health West Pac"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/0333102411408626","article-title":"Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million people","volume":"31","author":"Dekker F","year":"2011","unstructured":"Dekker F, Wiendels NJ, de Valk V, van der Vliet C, Knuistingh Neven A, Assendelft WJ, Ferrari MD. Triptan overuse in the Dutch general population: a nationwide pharmaco-epidemiology database analysis in 6.7 million people. Cephalalgia. 2011, 31:943-52. 10.1177\/0333102411408626","journal-title":"Cephalalgia"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.2147\/JPR.S207606","article-title":"Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonists","volume":"12","author":"Huber CA","year":"2019","unstructured":"Huber CA, Agosti R, N\u00e4pflin M, Blozik E. Treatment patterns in patients using triptan and prophylactic medication: an analysis of clinical practice prior to the introduction of CGRP antagonists. J Pain Res. 2019, 12:2211-21. 10.2147\/JPR.S207606","journal-title":"J Pain Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-018-0864-0","article-title":"Use and overuse of triptans in Austria - a survey based on nationwide healthcare claims data","volume":"19","author":"Zebenholzer K","year":"2018","unstructured":"Zebenholzer K, Gall W, W\u00f6ber C. Use and overuse of triptans in Austria - a survey based on nationwide healthcare claims data. J Headache Pain. 2018, 19:34. 10.1186\/s10194-018-0864-0","journal-title":"J Headache Pain"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.272630","article-title":"Pattern of triptans use: a retrospective prescription study in Calabria, Italy","volume":"15","author":"Scuteri D","year":"2020","unstructured":"Scuteri D, Adornetto A, Rombol\u00e0 L, et al.. Pattern of triptans use: a retrospective prescription study in Calabria, Italy. Neural Regen Res. 2020, 15:1340-3. 10.4103\/1673-5374.272630","journal-title":"Neural Regen Res"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1177\/0333102414550419","article-title":"Triptan use in Italy: insights from administrative databases","volume":"35","author":"Da Cas R","year":"2015","unstructured":"Da Cas R, Nigro A, Terrazzino S, et al.. Triptan use in Italy: insights from administrative databases. Cephalalgia. 2015, 35:619-26. 10.1177\/0333102414550419","journal-title":"Cephalalgia"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1177\/0333102415570497","article-title":"Triptans use and overuse: a pharmacoepidemiology study from the French health insurance system database covering 4.1 million people","volume":"35","author":"Braunstein D","year":"2015","unstructured":"Braunstein D, Donnet A, Pradel V, Sciortino V, Allaria-Lapierre V, Lant\u00e9ri-Minet M, Micallef J. Triptans use and overuse: a pharmacoepidemiology study from the French health insurance system database covering 4.1 million people. Cephalalgia. 2015, 35:1172-80. 10.1177\/0333102415570497","journal-title":"Cephalalgia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1177\/0333102419851855","article-title":"Treatment patterns and characteristics of patients with migraine in Japan: a retrospective analysis of health insurance claims data","volume":"39","author":"Meyers JL","year":"2019","unstructured":"Meyers JL, Davis KL, Lenz RA, Sakai F, Xue F. Treatment patterns and characteristics of patients with migraine in Japan: a retrospective analysis of health insurance claims data. Cephalalgia. 2019, 39:1518-34. 10.1177\/0333102419851855","journal-title":"Cephalalgia"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-022-01439-3","article-title":"A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan","volume":"23","author":"Sakai F","year":"2022","unstructured":"Sakai F, Hirata K, Igarashi H, et al.. A study to investigate the prevalence of headache disorders and migraine among people registered in a health insurance association in Japan. J Headache Pain. 2022, 23:70. 10.1186\/s10194-022-01439-3","journal-title":"J Headache Pain"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-023-03122-9","article-title":"Clinical characteristics, medication use, and impact of primary headache on daily activities: an observational study using linked online survey and medical claims data in Japan","volume":"23","author":"Hirata K","year":"2023","unstructured":"Hirata K, Sano H, Kondo H, Shibasaki Y, Koga N. Clinical characteristics, medication use, and impact of primary headache on daily activities: an observational study using linked online survey and medical claims data in Japan. BMC Neurol. 2023, 23:80. 10.1186\/s12883-023-03122-9","journal-title":"BMC Neurol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-024-01722-5","article-title":"Treatment patterns and characteristics of patients with migraine: results from a retrospective database study in Japan","volume":"25","author":"Takizawa T","year":"2024","unstructured":"Takizawa T, Kitano T, Iijima M, Togo K, Yonemoto N. Treatment patterns and characteristics of patients with migraine: results from a retrospective database study in Japan. J Headache Pain. 2024, 25:19. 10.1186\/s10194-024-01722-5","journal-title":"J Headache Pain"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1177\/03331024231226177","article-title":"Treatment patterns and characteristics of headache in patients in Japan: a retrospective cross-sectional and longitudinal analysis of health insurance claims data","volume":"44","author":"Katsuki M","year":"2024","unstructured":"Katsuki M, Matsumori Y, Ichihara T, et al.. Treatment patterns and characteristics of headache in patients in Japan: a retrospective cross-sectional and longitudinal analysis of health insurance claims data. Cephalalgia. 2024, 44:4-6. 10.1177\/03331024231226177","journal-title":"Cephalalgia"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/life14010096","article-title":"Treatment patterns for and characteristics of headache in children and adolescents aged 6-17 years in Japan: a retrospective cross-sectional and longitudinal analysis of health insurance claims data","volume":"14","author":"Katsuki M","year":"2024","unstructured":"Katsuki M, Matsumori Y, Ichihara T, et al.. Treatment patterns for and characteristics of headache in children and adolescents aged 6-17 years in Japan: a retrospective cross-sectional and longitudinal analysis of health insurance claims data. Life (Basel). 2024, 14:16-8. 10.3390\/life14010096","journal-title":"Life (Basel)"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.37380","article-title":"School-based stroke education through on-demand E-learning during coronavirus disease 2019 pandemic: Itoigawa Stroke Awareness Campaign","volume":"15","author":"Katsuki M","year":"2023","unstructured":"Katsuki M, Kawahara J, Senda H, et al.. School-based stroke education through on-demand E-learning during coronavirus disease 2019 pandemic: Itoigawa Stroke Awareness Campaign. Cureus. 2023, 15:e37380. 10.7759\/cureus.37380","journal-title":"Cureus"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-2982.1997.1701015.x","article-title":"Prevalence of migraine in Japan: a nationwide survey","volume":"17","author":"Sakai F","year":"1997","unstructured":"Sakai F, Igarashi H. Prevalence of migraine in Japan: a nationwide survey. Cephalalgia. 1997, 17:15-22. 10.1046\/j.1468-2982.1997.1701015.x","journal-title":"Cephalalgia"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-019-1012-1","article-title":"Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme","volume":"20","author":"Ueda K","year":"2019","unstructured":"Ueda K, Ye W, Lombard L, et al.. Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme. J Headache Pain. 2019, 20:68. 10.1186\/s10194-019-1012-1","journal-title":"J Headache Pain"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.ynpai.2022.100094","article-title":"Neurobiology of migraine progression","volume":"12","author":"Rattanawong W","year":"2022","unstructured":"Rattanawong W, Rapoport A, Srikiatkhachorn A. Neurobiology of migraine progression. Neurobiol Pain. 2022, 12:100094. 10.1016\/j.ynpai.2022.100094","journal-title":"Neurobiol Pain"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-022-02289-w","article-title":"Potential unmet needs in acute treatment of migraine in Japan: Results of the OVERCOME (Japan) study","volume":"39","author":"Takeshima T","year":"2022","unstructured":"Takeshima T, Ueda K, Komori M, et al.. Potential unmet needs in acute treatment of migraine in Japan: Results of the OVERCOME (Japan) study. Adv Ther. 2022, 39:5176-90. 10.1007\/s12325-022-02289-w","journal-title":"Adv Ther"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s40120-021-00305-9","article-title":"Burden of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study","volume":"11","author":"Matsumori Y","year":"2022","unstructured":"Matsumori Y, Ueda K, Komori M, et al.. Burden of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study. Neurol Ther. 2022, 11:205-22. 10.1007\/s40120-021-00305-9","journal-title":"Neurol Ther"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1177\/0333102418825373","article-title":"Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients","volume":"39","author":"Pavlovic JM","year":"2019","unstructured":"Pavlovic JM, Yu JS, Silberstein SD, et al.. Development of a claims-based algorithm to identify potentially undiagnosed chronic migraine patients. Cephalalgia. 2019, 39:465-76. 10.1177\/0333102418825373","journal-title":"Cephalalgia"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1177\/0333102417736898","article-title":"National awareness campaign to prevent medication-overuse headache in Denmark","volume":"38","author":"Carlsen LN","year":"2018","unstructured":"Carlsen LN, Westergaard ML, Bisgaard M, Schytz JB, Jensen RH. National awareness campaign to prevent medication-overuse headache in Denmark. Cephalalgia. 2018, 38:1316-25. 10.1177\/0333102417736898","journal-title":"Cephalalgia"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2009.05333.x","article-title":"Neighborhoods and health","volume":"1186","author":"Diez Roux AV","year":"2010","unstructured":"Diez Roux AV, Mair C. Neighborhoods and health. Ann N Y Acad Sci. 2010, 1186:125-45. 10.1111\/j.1749-6632.2009.05333.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1161\/01.STR.0000097610.12803.D7","article-title":"Effect of area-based deprivation on the severity, subtype, and outcome of ischemic stroke","volume":"34","author":"Aslanyan S","year":"2003","unstructured":"Aslanyan S, Weir CJ, Lees KR, Reid JL, McInnes GT. Effect of area-based deprivation on the severity, subtype, and outcome of ischemic stroke. Stroke. 2003, 34:2623-8. 10.1161\/01.STR.0000097610.12803.D7","journal-title":"Stroke"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5753.77","article-title":"Migraine: intelligence, social class, and familial prevalence","volume":"2","author":"Waters WE","year":"1971","unstructured":"Waters WE. Migraine: intelligence, social class, and familial prevalence. Br Med J. 1971, 2:77-81. 10.1136\/bmj.2.5753.77","journal-title":"Br Med J"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05831-w","article-title":"Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study","volume":"43","author":"Katsuki M","year":"2022","unstructured":"Katsuki M, Yamagishi C, Matsumori Y, et al.. Questionnaire-based survey on the prevalence of medication-overuse headache in Japanese one city-Itoigawa study. Neurol Sci. 2022, 43:3811-22. 10.1007\/s10072-021-05831-w","journal-title":"Neurol Sci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1186\/s12942-021-00296-8","article-title":"Differences in depressive symptoms by rurality in Japan: a cross-sectional multilevel study using different aggregation units of municipalities and neighborhoods (JAGES)","volume":"20","author":"Kanamori M","year":"2021","unstructured":"Kanamori M, Hanazato M, Takagi D, Kondo K, Ojima T, Amemiya A, Kondo N. Differences in depressive symptoms by rurality in Japan: a cross-sectional multilevel study using different aggregation units of municipalities and neighborhoods (JAGES). Int J Health Geogr. 2021, 20:42. 10.1186\/s12942-021-00296-8","journal-title":"Int J Health Geogr"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2021.1971179","article-title":"Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study","volume":"37","author":"Hirata K","year":"2021","unstructured":"Hirata K, Ueda K, Komori M, et al.. Comprehensive population-based survey of migraine in Japan: results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) study. Curr Med Res Opin. 2021, 37:1945-55. 10.1080\/03007995.2021.1971179","journal-title":"Curr Med Res Opin"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/314086-treatment-patterns-characteristics-and-probable-acute-medication-overprescription-among-patients-with-migraine-in-japan-a-retrospective-cross-sectional-and-longitudinal-analysis-of-health-insurance-claims-data","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T09:45:48Z","timestamp":1734515148000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/314086-treatment-patterns-characteristics-and-probable-acute-medication-overprescription-among-patients-with-migraine-in-japan-a-retrospective-cross-sectional-and-longitudinal-analysis-of-health-insurance-claims-data"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":39,"URL":"https:\/\/doi.org\/10.7759\/cureus.75928","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,18]]}}}